$2.47 Billion is the total value of Artal Group S.A.'s 109 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 49.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS INC | $378,915,000 | +13.1% | 60,240,864 | 0.0% | 15.32% | +12.0% | |
| WW | WEIGHT WATCHERS INTL INC NEW | $283,030,000 | -5.2% | 14,818,300 | 0.0% | 11.45% | -6.1% | |
| AVTR | New | AVANTOR INC | $133,630,000 | – | 7,000,000 | +100.0% | 5.40% | – |
| BMY | Buy | BRISTOL MYERS SQUIBB COcall | $102,038,000 | +229.0% | 2,250,000 | +246.2% | 4.13% | +226.0% |
| BGNE | Buy | BEIGENE LTDsponsored adr | $80,568,000 | +1.7% | 650,000 | +8.3% | 3.26% | +0.7% |
| BABA | Buy | ALIBABA GROUP HLDG LTDsponsored ads | $76,253,000 | +1.4% | 450,000 | +9.2% | 3.08% | +0.5% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $70,748,000 | +4.0% | 750,000 | -11.8% | 2.86% | +3.0% |
| NVDA | NVIDIA CORP | $68,977,000 | -8.5% | 420,000 | 0.0% | 2.79% | -9.4% | |
| MRNA | Sell | MODERNA INC | $67,436,000 | -33.8% | 4,606,298 | -8.0% | 2.73% | -34.4% |
| XLRN | Sell | ACCELERON PHARMA INC | $61,620,000 | -19.8% | 1,500,000 | -9.1% | 2.49% | -20.6% |
| Z | Buy | ZILLOW GROUP INCcl c cap stk | $46,390,000 | +1235.3% | 1,000,000 | +900.0% | 1.88% | +1221.1% |
| RUBY | Sell | RUBIUS THERAPEUTICS INC | $44,576,000 | -15.3% | 2,833,791 | -2.6% | 1.80% | -16.1% |
| GM | GENERAL MTRS COcall | $38,530,000 | +3.9% | 1,000,000 | 0.0% | 1.56% | +2.8% | |
| SRRK | SCHOLAR ROCK HLDG CORP | $37,208,000 | -15.6% | 2,346,040 | 0.0% | 1.50% | -16.4% | |
| MDCO | Buy | MEDICINES CO | $36,470,000 | +86.4% | 1,000,000 | +42.9% | 1.48% | +84.6% |
| GOSS | Sell | GOSSAMER BIO INC | $35,687,000 | -0.7% | 1,608,968 | -3.0% | 1.44% | -1.7% |
| BABA | New | ALIBABA GROUP HLDG LTDcall | $33,890,000 | – | 200,000 | +100.0% | 1.37% | – |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $31,200,000 | -11.8% | 2,500,000 | -3.8% | 1.26% | -12.6% |
| ARGX | Buy | ARGENX SEsponsored adr | $31,148,000 | +24.8% | 220,000 | +10.0% | 1.26% | +23.5% |
| FATE | Sell | FATE THERAPEUTICS INC | $30,450,000 | -3.7% | 1,500,000 | -16.7% | 1.23% | -4.6% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $29,024,000 | -31.0% | 400,000 | -11.1% | 1.17% | -31.6% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $27,464,000 | +38.1% | 150,000 | +20.0% | 1.11% | +36.8% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $24,940,000 | -7.5% | 500,000 | +25.0% | 1.01% | -8.4% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $24,906,000 | -17.6% | 700,000 | -22.2% | 1.01% | -18.5% |
| UBER | New | UBER TECHNOLOGIES INC | $23,190,000 | – | 500,000 | +100.0% | 0.94% | – |
| ATRA | ATARA BIOTHERAPEUTICS INC | $23,127,000 | -49.4% | 1,150,000 | 0.0% | 0.94% | -49.9% | |
| MLCO | Buy | MELCO RESORTS AND ENTMT LTDcall | $21,720,000 | +28.2% | 1,000,000 | +33.3% | 0.88% | +26.9% |
| INCY | New | INCYTE CORPcall | $21,240,000 | – | 250,000 | +100.0% | 0.86% | – |
| EPZM | Sell | EPIZYME INC | $20,708,000 | -4.5% | 1,650,000 | -5.7% | 0.84% | -5.3% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $17,273,000 | +17.4% | 150,000 | +20.0% | 0.70% | +16.3% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $17,164,000 | +261.0% | 700,000 | +40.0% | 0.69% | +257.7% |
| NBIX | NEUROCRINE BIOSCIENCES INCcall | $16,886,000 | -4.2% | 200,000 | 0.0% | 0.68% | -5.0% | |
| NVDA | New | NVIDIA CORPcall | $16,423,000 | – | 100,000 | +100.0% | 0.66% | – |
| AAL | AMERICAN AIRLS GROUP INCcall | $16,305,000 | +2.7% | 500,000 | 0.0% | 0.66% | +1.7% | |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $15,750,000 | +9.8% | 1,000,000 | +2.1% | 0.64% | +8.7% |
| CYCN | New | CYCLERION THERAPEUTICS INC | $15,590,000 | – | 1,361,584 | +100.0% | 0.63% | – |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $15,450,000 | +20.4% | 150,000 | -14.3% | 0.62% | +19.3% |
| ALBO | Sell | ALBIREO PHARMA INC | $14,508,000 | -9.9% | 450,000 | -10.0% | 0.59% | -10.8% |
| TCDA | Buy | TRICIDA INC | $14,206,000 | +63.5% | 360,000 | +60.0% | 0.58% | +62.0% |
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $13,251,000 | -15.1% | 350,000 | -12.5% | 0.54% | -15.9% |
| BLUE | BLUEBIRD BIO INC | $12,720,000 | -19.2% | 100,000 | 0.0% | 0.51% | -19.9% | |
| HTHT | Buy | HUAZHU GROUP LTDsponsored ads | $12,688,000 | +100.7% | 350,000 | +133.3% | 0.51% | +98.8% |
| NIO | Buy | NIO INCsponsored ads | $12,368,000 | -47.3% | 4,850,000 | +5.4% | 0.50% | -47.8% |
| KRYS | KRYSTAL BIOTECH INC | $12,081,000 | +22.4% | 300,000 | 0.0% | 0.49% | +21.3% | |
| PRQR | Sell | PROQR THRAPEUTICS N V | $11,830,000 | -39.1% | 1,300,000 | -7.1% | 0.48% | -39.7% |
| XNCR | Sell | XENCOR INC | $11,256,000 | -27.5% | 275,000 | -45.0% | 0.46% | -28.2% |
| CHNG | New | CHANGE HEALTHCARE INC | $10,950,000 | – | 750,000 | +100.0% | 0.44% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INCcall | $10,884,000 | – | 150,000 | +100.0% | 0.44% | – |
| KLDO | Sell | KALEIDO BIOSCIENCES INC | $10,446,000 | -24.0% | 900,500 | -5.0% | 0.42% | -24.8% |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $10,296,000 | -2.0% | 450,000 | -10.0% | 0.42% | -3.0% |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $10,005,000 | +46.6% | 850,000 | +70.0% | 0.40% | +45.2% |
| MORF | New | MORPHIC HLDG INC | $9,910,000 | – | 500,000 | +100.0% | 0.40% | – |
| ADPT | New | ADAPTIVE BIOTECHNOLOGIES COR | $9,660,000 | – | 200,000 | +100.0% | 0.39% | – |
| TBIO | Buy | TRANSLATE BIO INC | $9,473,000 | +54.9% | 750,000 | +25.0% | 0.38% | +53.2% |
| YMAB | New | Y MABS THERAPEUTICS INC | $9,148,000 | – | 400,000 | +100.0% | 0.37% | – |
| STNE | New | STONECO LTD | $8,874,000 | – | 300,000 | +100.0% | 0.36% | – |
| REPL | REPLIMUNE GROUP INC | $8,796,000 | -3.7% | 600,000 | 0.0% | 0.36% | -4.6% | |
| DNLI | DENALI THERAPEUTICS INC | $8,304,000 | -10.6% | 400,000 | 0.0% | 0.34% | -11.3% | |
| FGEN | Sell | FIBROGEN INC | $8,132,000 | -25.2% | 180,000 | -10.0% | 0.33% | -25.9% |
| TPTX | New | TURNING POINT THERAPEUTICS I | $8,140,000 | – | 200,000 | +100.0% | 0.33% | – |
| AUTL | Buy | AUTOLUS THERAPEUTICS PLCsponsored ads | $8,050,000 | -43.2% | 500,000 | +11.1% | 0.33% | -43.6% |
| TGTX | Buy | TG THERAPEUTICS INC | $7,785,000 | +21.0% | 900,000 | +12.5% | 0.32% | +19.8% |
| ARQL | New | ARQULE INC | $7,707,000 | – | 700,000 | +100.0% | 0.31% | – |
| HOOK | New | HOOKIPA PHARMA INC | $7,636,000 | – | 1,134,616 | +100.0% | 0.31% | – |
| AGEN | Sell | AGENUS INC | $7,500,000 | -8.2% | 2,500,000 | -9.1% | 0.30% | -9.3% |
| RGNX | Sell | REGENXBIO INC | $7,449,000 | -23.5% | 145,000 | -14.7% | 0.30% | -24.4% |
| MRNA | New | MODERNA INCcall | $7,320,000 | – | 500,000 | +100.0% | 0.30% | – |
| TCRR | TCR2 THERAPEUTICS INC | $7,012,000 | -17.9% | 490,000 | 0.0% | 0.28% | -18.6% | |
| SLDB | SOLID BIOSCIENCES INC | $6,900,000 | -37.5% | 1,200,000 | 0.0% | 0.28% | -38.1% | |
| CRWD | New | CROWDSTRIKE HLDGS INCcl a | $6,829,000 | – | 100,000 | +100.0% | 0.28% | – |
| SPRO | Sell | SPERO THERAPEUTICS INC | $6,215,000 | -19.1% | 540,000 | -10.0% | 0.25% | -20.1% |
| GRTS | Buy | GRITSTONE ONCOLOGY INC | $5,570,000 | +109.4% | 500,000 | +150.0% | 0.22% | +106.4% |
| ACIU | AC IMMUNE SA | $5,550,000 | +9.9% | 1,000,000 | 0.0% | 0.22% | +8.7% | |
| STML | Sell | STEMLINE THERAPEUTICS INC | $5,515,000 | +7.3% | 360,000 | -10.0% | 0.22% | +6.2% |
| BBIO | New | BRIDGEBIO PHARMA INC | $5,394,000 | – | 200,000 | +100.0% | 0.22% | – |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $5,400,000 | -23.0% | 360,000 | -10.0% | 0.22% | -23.8% |
| ALLO | Sell | ALLOGENE THERAPEUTICS INC | $5,370,000 | -53.6% | 200,000 | -50.0% | 0.22% | -54.0% |
| MRUS | Buy | MERUS N V | $5,128,000 | +15.7% | 350,000 | +16.7% | 0.21% | +14.4% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INCcall | $4,988,000 | -63.0% | 100,000 | -50.0% | 0.20% | -63.3% |
| ORTX | New | ORCHARD THERAPEUTICS PLCads | $4,897,000 | – | 350,000 | +100.0% | 0.20% | – |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $4,710,000 | -9.1% | 100,000 | -31.0% | 0.19% | -10.0% |
| NIO | NIO INCcall | $4,463,000 | -50.0% | 1,750,000 | 0.0% | 0.18% | -50.3% | |
| FTDR | New | FRONTDOOR INC | $4,355,000 | – | 100,000 | +100.0% | 0.18% | – |
| SGMO | Buy | SANGAMO THERAPEUTICS INC | $4,362,000 | +14.3% | 405,000 | +1.2% | 0.18% | +12.8% |
| ALEC | Sell | ALECTOR INC | $4,275,000 | -8.7% | 225,000 | -10.0% | 0.17% | -9.4% |
| SELB | SELECTA BIOSCIENCES INC | $3,759,000 | -24.5% | 2,100,000 | 0.0% | 0.15% | -25.1% | |
| TORC | Sell | RESTORBIO INC | $3,672,000 | +34.6% | 360,000 | -10.0% | 0.15% | +34.2% |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $3,668,000 | -16.3% | 35,000 | 0.0% | 0.15% | -17.3% | |
| AXLA | New | AXCELLA HEALTH INC | $3,628,000 | – | 389,741 | +100.0% | 0.15% | – |
| NKTR | NEKTAR THERAPEUTICScall | $3,558,000 | +5.9% | 100,000 | 0.0% | 0.14% | +5.1% | |
| TWST | Sell | TWIST BIOSCIENCE CORP | $2,901,000 | -16.6% | 100,000 | -33.3% | 0.12% | -17.6% |
| YI | 111 INCads | $2,502,000 | -14.3% | 450,000 | 0.0% | 0.10% | -15.1% | |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $2,147,000 | -42.7% | 270,000 | -10.0% | 0.09% | -43.1% |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $2,057,000 | -47.1% | 425,000 | -10.5% | 0.08% | -47.8% |
| ARAV | Buy | ARAVIVE INC | $1,845,000 | +2.3% | 307,466 | +20.0% | 0.08% | +1.4% |
| ADRO | ADURO BIOTECH INC | $1,540,000 | -61.3% | 1,000,000 | 0.0% | 0.06% | -62.0% | |
| NGM | New | NGM BIOPHARMACEUTICALS INC | $1,464,000 | – | 100,000 | +100.0% | 0.06% | – |
| AVRO | Sell | AVROBIO INC | $1,463,000 | -33.7% | 90,000 | -10.0% | 0.06% | -34.4% |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $1,209,000 | -3.4% | 110,532 | 0.0% | 0.05% | -3.9% | |
| AGLE | New | AEGLEA BIOTHERAPEUTICS INC | $1,157,000 | – | 168,954 | +100.0% | 0.05% | – |
| VKTX | New | VIKING THERAPEUTICS INC | $830,000 | – | 100,000 | +100.0% | 0.03% | – |
| REAL | New | THE REALREAL INC | $578,000 | – | 20,000 | +100.0% | 0.02% | – |
| MGTA | Sell | MAGENTA THERAPEUTICS INC | $347,000 | -89.5% | 23,524 | -88.2% | 0.01% | -89.6% |
| Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.00% | – | |
| NVLNF | Exit | NOVELION THERAPEUTICS INC | $0 | – | -256,400 | -100.0% | -0.01% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -500,000 | -100.0% | -0.04% | – |
| TIGR | Exit | UP FINTECH HLDG LTDsponsored ads | $0 | – | -100,000 | -100.0% | -0.05% | – |
| ARPO | Exit | AERPIO PHARMACEUTICALS INC | $0 | – | -1,558,400 | -100.0% | -0.06% | – |
| MGEN | Exit | MIRAGEN THERAPEUTICS INC | $0 | – | -500,000 | -100.0% | -0.06% | – |
| ZFGN | Exit | ZAFGEN INC | $0 | – | -700,000 | -100.0% | -0.08% | – |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -200,000 | -100.0% | -0.09% | – |
| DTIL | Exit | PRECISION BIOSCIENCES INC | $0 | – | -150,000 | -100.0% | -0.11% | – |
| CRNX | Exit | CRINETICS PHARMACEUTICALS IN | $0 | – | -200,000 | -100.0% | -0.19% | – |
| SWAV | Exit | SHOCKWAVE MED INC | $0 | – | -150,000 | -100.0% | -0.20% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -50,000 | -100.0% | -0.23% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -300,000 | -100.0% | -0.24% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INCcall | $0 | – | -500,000 | -100.0% | -0.28% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -600,000 | -100.0% | -0.32% | – |
| VICI | Exit | VICI PPTYS INC | $0 | – | -400,000 | -100.0% | -0.36% | – |
| XLRN | Exit | ACCELERON PHARMA INCcall | $0 | – | -200,000 | -100.0% | -0.38% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -250,000 | -100.0% | -0.40% | – |
| AMRN | Exit | AMARIN CORP PLCcall | $0 | – | -500,000 | -100.0% | -0.42% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -200,000 | -100.0% | -0.45% | – |
| QCOM | Exit | QUALCOMM INCcall | $0 | – | -200,000 | -100.0% | -0.47% | – |
| IFRX | Exit | INFLARX NV | $0 | – | -825,000 | -100.0% | -1.27% | – |
| GS | Exit | GOLDMAN SACHS GROUP INCcall | $0 | – | -250,000 | -100.0% | -1.96% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -2,000,000 | -100.0% | -1.99% | – |
| BAC | Exit | BANK AMER CORPcall | $0 | – | -2,000,000 | -100.0% | -2.25% | – |
| CELG | Exit | CELGENE CORPcall | $0 | – | -750,000 | -100.0% | -2.89% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.